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Abstract
Background: The purpose of this study was to determine the standard tasks performed by clinical
research coordinators (CRCs) in oncology clinical trials.
Methods:  Forty-one CRCs were anonymously surveyed, using a four-page self-administered
questionnaire focused on demographics, qualifications, and professional experience. The survey
questions on responsibilities consisted of an ad-hoc 32-item questionnaire where respondents had
to rate the frequency of involvement in the listed activities using a 3-point scale. We defined as
"standard" a task that was rated as "in all or nearly all trials" by at least half of the respondents.
Results: A response rate of 90% (37 out of 41) was achieved after two mailings. Less than half of
the respondents had received additional training in oncology, clinical research or Good Clinical
Practices (GCP). Overall, all standard tasks performed by CRCs were in the category of
"monitoring activities" (those usually performed by a Clinical Research Associate "CRA") and
included patient registration/randomization, recruitment follow-up, case report form completion,
collaboration with the CRA, serious adverse events reporting, handling of investigator files, and
preparing the site for and/or attending audits.
Conclusions: CRCs play a key role in the implementation of oncology clinical trials, which goes
far beyond mere data collection and/or administrative support, and directly contributes to the
gathering of good quality data.
Background
Randomized, controlled trials represent the most defini-
tive method to determine the effectiveness or ineffective-
ness of a cancer intervention [1,2]. In addition, when
meeting very rigid medical, scientific and ethical stand-
ards, they also represent "Good Medicine" (i.e. a standard
of care) [2].
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Nowadays it is widely accepted that the design, imple-
mentation, coordination and analysis of modern clinical
trials require a multidisciplinary specialist approach [3].
The basic research team includes the principal investiga-
tor, sub-investigators, clinical monitors (also called clini-
cal research associates or "CRAs"), the data management
team, statisticians, and a relatively recent position: the
clinical research coordinator (CRC). The CRC, regardless
of job title (study or site coordinator, data manager,
research nurse, etc), plays a key role in the clinical trial
process [3-8].
The responsibilities of investigators, sponsors and moni-
tors are well defined in the Spanish regulation on clinical
trials [9], FDA regulations [10] and international guide-
lines on Good Clinical Practice [11]. Despite the above-
mentioned importance of the CRC position however,
their responsibilities and main tasks have not been for-
mally described. Furthermore, literature on this topic is
limited since most papers mainly address the required
skills of a CRC [4,8,12], or describe their responsibilities
within a specific project [13,14]. The British Oncology
Data Managers Association (BODMA) has run several sur-
veys among its members [3,15] but very little data has
been published in journals accessible by commonly used
literature databases (e.g. MEDLINE) [3]. Raybuck [16], in
a review of the literature, concluded that their role is vague
and ill defined, with little emphasis on the need for
advanced educational preparation. Arrigo et al [7] carried
out the only published survey that we are aware of
addressing this issue. They surveyed 120 nurses in the
EORTC Oncology Nurses Study Group. Their results indi-
cate that nurses' tasks and activities are oriented primarily
toward patient care, such as informing patients, drug
preparation and administration, monitoring of toxicities,
organization of follow-up, basic patient care, and data
management. However, we think that this otherwise inter-
esting survey has two important limitations. First of all,
only nurses were surveyed, and it is well recognized that
CRCs have a broader range of backgrounds [15,17]. Sec-
ondly, their report did not state the content and format of
the questions used, and therefore we cannot know
whether these activities are the standard ones (i.e. activi-
ties which are performed by most of the respondents in
most of the trials).
The purpose of our study was to determine the standard
tasks performed by CRCs in oncology clinical trials. In
addition, we assessed their job satisfaction and training
needs.
Methods
Survey creation
We created a four-page self-administered questionnaire
with three main sections:
1. Demographic data: sex and age
2. Qualifications: highest educational level of respond-
ents, language skills (upper-intermediate level), and other
training received. The latter was included to ascertain
whether they received any structured training in oncology,
clinical research, clinical trials, statistics, Good Clinical
Practice, data management, or other training.
3. Professional experience: this was the core section of the
survey. We collected data on: current and previous experi-
ence as a CRC; previous experience in the pharmaceutical
industry or in a contract research organization (CRO);
current job title; workload, defined as the number and
phases of the clinical trials they were currently participat-
ing in (i.e. those currently recruiting patients), number of
patients included and number of monitoring visits
received per month; responsibilities (see below); job
importance, determined using a visual analogue scale of 1
("not important") to 10 ("very important"); job satisfac-
tion, using a 7-item likert scale where 1 was "extremely dis-
satisfied", 4 "neither satisfied nor dissatisfied", and 7
"extremely satisfied"; and finally an evaluation of training
needs.
The survey questions on responsibilities were created ad-
hoc since we did not find any such questionnaire in the
literature. In the first draft, we listed tasks related to the
whole clinical trial process with which investigators, CRAs
and ancillary personnel are usually involved. We added
two general data management items, and one statistician
question. We interviewed 2 CRCs by phone and asked
them to list all the activities they usually perform. Any
activities that were not originally in the first version were
included. All authors reviewed this second version and a
final 32-item questionnaire was agreed upon (Figure 1).
Respondents were asked to rate the frequency of involve-
ment in the listed activities using a 3-point scale, modified
from a format developed by the RAND Corporation for
ascertaining expert consensus [18]. In this scale, 1 was "in
none or few trials" (≤ 25% of the trials they are currently
participating in), 2 was "in some trials" (26–75% of the
trials), and 3 was "in all or nearly all trials" (>75% of the
trials). A copy of this questionnaire and the complete sur-
vey are available from the authors upon request.
Sampling method
The Spanish Lung Cancer Group sent this anonymous sur-
vey to 41 CRCs who were going to attend a course on clin-
ical trials in oncology. An accompanying letter explained
the aim of the survey and indicated the deadline for
returning it either by fax or ordinary mail. A reminder was
sent by the study co-sponsor (Biométrica) to solicit out-
standing questionnaires.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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Tasks of the Clinical Research Coordinators Figure 1
Tasks of the Clinical Research Coordinators
*
*
*
*
*
*
*
*
Administrative activities 
Management of IRB submission 
Management of Hospital Director submission 
Management Medicine Agency submission 
Medical history adaptation for the CT 
Scheduled protocol specified tests 
Scheduled patient’s CT appointments
Clinical activities
To identify potential eligible patients 
Assessment of inclusion/exclusion criteria 
Participation in informing of patients 
Participation in obtaining informed consent 
To assess response to therapy 
To assess toxicities 
Scales/questionnaires completion 
Monitoring activities
Patient registration/randomization 
To deal with Hospital Pharmacy 
To deal with a central lab 
Recruitment follow-up 
CRF completion 
To act as CRA 
To collaborate with the CRA 
Queries resolution 
Reporting serious adverse events 
To handle the investigator file 
To prepare and/or attend audits
Data management and statistics
Database set-up   
Data entry 
Statistical analysis
Researcher-related activities 
Participation in protocol/CRF design 
Participation in protocol/CRF review 
Attending investigators meeting 
Participation in Final Report 
Participation in CT publication 
                                                                                 1                             2                             3
             *Standard Tasks (i.e. those performed by at least 50% of the respondents in most of the trials)
             1:“in none or few trials”; 2=”in some trials”; 3=”in all or near all trials” 
             Abbreviations: CRA: clinical research associate; CRF: case report form; IRB: institutional review board 
1.55 (0.36)  N.A. 
1.78 (0.76)  19.4% 
1.31 (0.67)  11.1% 
1.00 (0.00)  0.0% 
1.64 (0.86)  25.0% 
1.67 (0.79)  19.4% 
1.83 (0.84)  27.8%
1.66 (0.54)  N.A. 
1.72 (0.85)  25.0% 
1.83 (0.85)  27.8% 
1.40 (0.70)  11.4% 
1.47 (0.74)  13.9% 
1.42 (0.69)  11.1% 
1.58 (0.81)  19.4% 
2.17 (0.81)  41.7%
2.45 (0.27)  N.A. 
2.94 (0.23)  94.4% 
1.89 (0.66)  16.2% 
1.60 (0.81)  20.0% 
2.70 (0.62)  78.4% 
2.84 (0.50)  89.2% 
1.56 (0.81)  19.4% 
2.70 (0.54)  74.1%
2.68 (0.63)  75.7% 
2.95 (0.23)  94.6% 
2.89 (0.32)  89.2% 
2.25 (0.87)  52.8%
1.49 (0.59)  N.A. 
1.58 (0.77)  16.7% 
1.69 (0.79)  19.4% 
1.19 (0.47)  2.8%
1.30 (0.38)  N.A. 
1.08 (0.28)  0.0% 
1.17 (0.51)  5.7% 
1.78 (0.80)  22.2% 
1.28 (0.51)  2.8% 
1.14 (0.40)  0.0%
Primary 
task  Secondary task 
Tertiary 
task      Mean (SD)      Scoring ‘3’  BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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Data analysis
Returned surveys were checked for duplication using three
variables: age, sex, and geographical region where the
CRC was working. Only the first reply was tabulated. After
study data were tabulated and quality control was per-
formed, the results were analyzed using the statistical
package SPSS, version 10.0 [19].
In the descriptive analysis, the mean or median, standard
deviation and range were calculated for the quantitative
variables, and the frequency and percentage of answers in
each category for the qualitative variables. Answers to the
questionnaire on responsibilities were analyzed in the fol-
lowing manner. We first calculated the mean, standard
deviation and 95% confidence interval (CI) for each item.
We defined as "standard" any CRC task that was rated as
a 3 ("in all or near all trials") by at least half of the
respondents. In addition, CRC activities were grouped
somewhat arbitrarily into five categories: administrative
(those that could be done by a trained secretary); clinical
(those which required direct contact with the patient and/
or required some degree of clinical training/background);
monitoring (those usually performed by a CRA); data
management and statistics (those usually performed by
the data management department [i.e. database set-up
and data entry] and the statistics department [i.e. statisti-
cal analysis]); and researcher-related activities (those com-
monly performed by investigators).
Finally, an exploratory univariate analysis was performed
to test whether background (medical/nursing vs. others)
or frequency of participation in multinational clinical tri-
als influenced the job profile. Pairwise comparisons were
performed using the Mann-Whitney test, and they were
considered significant if P ≤ 0.05 (two-sided test).
Results
A response rate of 90% (37 out of 41) was achieved after
two mailings. Most of the respondents were female
(89.2%). Mean age was 30.4 years, ranging from 22 to 51.
The majority of respondents (89.2%) held a university
degree and had an English fluency level they considered
upper-intermediate (n = 34, 91.9%). Qualifications are
detailed in Table 1.
Professional experience and workload
More than two-thirds of the respondents (n = 26, 74.3%)
were called "Data Managers" while the title "Clinical
Research Coordinator" (i.e. titles that included both terms
"research" and "coordinator") appeared in only 3 (8.6%)
job titles. Mean duration of coordinator experience in the
current position and as a whole were 27.6 (SD: 29.7) and
36.9 (SD: 43.2) months respectively. Two-thirds of the
CRCs (23 out of 35 respondents, 65.7%) were devoted
full-time to their position, and only 24.3% (n = 9) had
previous experience in a similar position. Previous experi-
ence in the pharmaceutical industry or a CRO was
reported by 8.1% and 5.4% of the respondents, respec-
tively. Data on the CRCs' workload, expressed by the
number of trials they were currently involved in, type of
trial, and number of monitoring visits received, is pre-
sented in Table 2.
Table 1: Qualifications of the respondents
Educational level/Training received No. of CRCs %
University degree 31 83.8
Medicine 8 21.6
Pharmacy 5 13.5
Biology 5 13.5
Nursing 6 16.2
Other 7 19.0
Training received
Oncology 12 32.4
Clinical Research 17 45.9
Clinical Trials 20 54.1
GCP* 15 40.5
Statistics 8 21.6
Database preparation & management 9 24.3
*GCP: Good clinical PracticeBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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Clinical trial coordinator's tasks
The responsibilities questionnaire produced a list of CRC
tasks, identified in Figure 1. In analyzing the responses to
these survey questions, we first calculated the mean,
standard deviation and 95% CI for each item. The CI for
each task is represented by a horizontal bar, and the
numerical values are given in the table on the right. The
table also shows the percentage of respondents who rated
the task as a 3. The CI chart can be interpreted in two com-
plementary ways. Standard tasks (those having been rated
as a "3" by at least half of the respondents) are indicated
with an asterisk in the graphic. In addition, we have
divided the chart into three columns representing pri-
mary, secondary and tertiary tasks. When the confidence
interval falls entirely within the first column, we have con-
sidered it a "primary task" – one performed by most
respondents in most trials. Similarly, "secondary tasks"
are those performed by some or many of the respondents
in most trials, and "tertiary tasks" those performed by few
of the respondents in most trials.
Overall, CRCs seem to be devoted to what we have called
"monitoring activities" (Figure 1). All standard tasks fell
into this category, including patient registration/randomi-
zation, recruitment follow-up, CRF completion, collabo-
ration with the CRA, Serious Adverse Events (SAE)
reporting, investigator file handling, and preparing the
site for and/or attending audits. In addition, it was not
uncommon for the CRC to deal with the Hospital Phar-
macy. To a lesser extent, they were also involved in some
administrative activities (such as IRB submission and
scheduling patient's CT appointments), and various
clinical activities (inclusion/exclusion criteria assessment
and completion of scales/questionnaires,). Data manage-
ment and researcher-related activities as defined above
were underrepresented among the CRCs surveyed.
Table 2: Workload of the Clinical Research Coordinators
Parameter N Median Range
No. of current CTs* 37 12.5 2.0–46.0
No. of multinational CTs 33 4.0 0.0–17.5
No. of CTs by sponsorship: 34
Pharmaceutical Industry 4.0 0.0–30.0
Cooperative Groups 8.0 0.0–22.0
No. of CTs by Phase: 30
Phase I 0.0 0.0–3.0
Phase II 5.0 0.0–14.0
Phase III 5.0 0.0–28.0
Phase IV 0.5 0.0–5.0
Compassionate 0.0 0.0–3.0
No. of CTs by Indication: 27
Breast cancer 3.0 0.0–21.0
Lung cancer 3.0 0.0–13.0
Colorectal cancer 2.0 0.0–9.0
Head & Neck cancer 0.0 0.0–4.0
Ovarian cancer 0.0 0.0–2.0
Other 0.0 0.0–8.0
No. of patients: 33 %
0–25 NA 30.3
26–50 NA 15.2
51–75 NA 6.1
76–100 NA 12.1
>100 NA 36.3
No. of monitoring visits received: 
per month
2.0 0.0–10.0
*Current CTs: those that were currently recruiting patients CTs: clinical trials; N: number of respondents; NA: not applicableBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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Figures 2 and 3 show tasks profiles, and consider back-
ground (physicians and nurses vs. non-clinical) and
degree of involvement in multinational clinical trials. For
the latter, the group was divided into those involved in ≤
4 multinational trials, and those involved in > 4. We
present data for the category headings as well as for those
items that turned out to be standard tasks in either group.
This analysis suggests that the overall task profile is the
same regardless of the CRC's background or their involve-
ment in multinational trials. In any case, the CRCs are
mainly devoted to monitoring activities.
However, some interesting differences were found. Nurses
and physicians had greater involvement in clinical activi-
ties, such as completion of scales/questionnaires (P  =
0.054) and, although they were not rated as standard
tasks, response to therapy assessment (1.86 ± 0.86 vs. 1.14
± 0.36, P < 0.05) and toxicity assessment (2.14 ± 0.86 vs.
1.24 ± 0.54, P < 0.05). In addition, query resolution was
performed "in all or near all trials" by 100% of the nurses/
physicians, compared to 60.9% of the CRCs with a differ-
ent background. CRCs with greater involvement in multi-
national clinical trials were also more involved in CRF
completion, query resolution and audits (Figure 3).
Job importance and satisfaction
Most of the surveyed CRCs believed they play an impor-
tant role in oncology clinical trials (mean VAS score 7.6,
SD = 1.2, N = 37). Eighty-three percent of the respondents
were either extremely or very satisfied with their job.
Discussion
Our study has several limitations. First of all, our sample
size could be considered small although it represents 30%
(37 out of 120) of the CRCs currently working with the
Spanish Lung Cancer Group. Secondly, a selection bias
exists since we only surveyed those CRCs attending a
course on clinical trials. This might explain the high
CRC's Tasks according to their educational background Figure 2
CRC's Tasks according to their educational background
Clinical (Nurses & Physicians) vs non clinical
Administrative activities
Clinical activities
Monitoring activities
Data Management & Statistics
Researcher-related activities
Patients’ registration/randomization
Scales/questionnaires completion
Scheduled patient’s CT appointments
Recruitment follow-up
CRF completion
To collaborate with the CRA
Queries resolution
Reporting serious adverse events 
To handle investigator’s file
To prepare and/or attend the audits 
                                                                                    1                              2                             3 
                   Clinical background  (n=14)                     *  p < 0.05; Mann-Whitney 
                   Non-clinical background (n=23)               ¨ p= 0.054; Mann-Whitney 
1.68 (0.42) N.A.
1.46 (0.30)  N.A. 
1.91 (0.70)  N.A. 
1.50 (0.33)  N.A. 
2.58 (0.21)*  N.A. 
2.39 (0.27)  N.A. 
1.42 (0.68)  N.A. 
1.53 (0.53)  N.A. 
1.42 (0.56)  N.A. 
1.23 (0.19)  N.A. 
2.93 (0.27)  92.9% 
2.95 (0.21)  95.5% 
2.50 (0.65)¨ 57.1% 
1.95 (0.84)  31.8% 
2.07 (1.00)  50.0% 
1.68 (0.72)  13.6% 
2.79 (0.58)  85.7% 
2.65 (0.65)  73.9% 
2.79 (0.58)  85.7% 
2.87 (0.46)  91.3% 
2.63 (0.74)  75.0% 
2.74 (0.45)  73.7% 
3.00 (0.00)*  100% 
2.48 (0.73)  60.9% 
2.93 (0.27)  92.9% 
2.96 (0.21)  95.7% 
2.93 (0.27)  92.9% 
2.87 (0.34)  87.0% 
2.50 (0.76)  64.3% 
2.09 (0.92)  45.5% 
Mean (SD)          Scoring ‘3’   Primary 
tasks
Secondary tasks  Tertiary 
tasksBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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response rate to the survey. However, it is doubtful that
this bias affected the core results (i.e. identifying CRCs
tasks), since CRC's mean overall experience was 3 years
and we assume they have had enough experience to
illustrate the standard tasks of a CRC. However, this bias
might have affected secondary variables we studied. As the
CRCs interviewed were all attending training, they could
be considered highly motivated in their work, which
might bias both their job satisfaction as well as the impor-
tance they attribute to this role. Finally, we cannot be
assured that the task profile described is applicable to
other countries, as there lacks a systematic evaluation of
this topic.
In keeping with the findings of other authors, [15,17] our
sample contained a wide range of backgrounds. Although
most of the respondents held a university degree in health
sciences, it seems there are important training needs
which need to be addressed in areas such as oncology,
clinical trials, and especially GCP. This situation has also
been described in other reviews or studies carried out in
Europe[3,7,15]. Well-trained and experienced CRCs can
contribute significantly to the quality of data collected
[20]. At a minimum, we recommend an induction course
for those professionals recently appointed as CRCs. We
encourage those with greater working experience to
obtain certification, such as that provided by the Associa-
tion of Clinical Research Professionals [21]. Most impor-
tantly, GCP training is a key issue when conducting
clinical trials, and should be standard for those in charge
of data collection and its integrity, such as the CRCs sur-
veyed in our study. To highlight this point, the main
objectives of the recently formed EORTC CRC Group are
to make a positive impact upon the quality of clinical tri-
als, and create conditions and standards for implementing
and conducting clinical protocols according to Good
Clinical Practice [22].
Clinical research coordinators' main tasks seem to be
monitoring activities, regardless of their background. Not
unexpectedly, in addition to monitoring activities, nurses
and physicians performed more clinical activities than
CRC's Tasks according to the involvement in multinational CTs Figure 3
CRC's Tasks according to the involvement in multinational CTs
Administrative activities
Clinical activities
Monitoring activities
Data Management & Statistics
Researcher-related activities
Patients’s registration/randomization
Scales/questionnaires completion
Recruitment follow-up
CRF completion
To collaborate with the CRA
Queries resolution
Reporting serious adverse events
To handle investigator’s file
To prepare and/or attend the audits 
                                                                                    1                              2                             3 
                   > 4 multinational CTs (n=16)                    * p < 0.05; Mann-Whitney 
                    4 multinational CTs (n=17)                                    
1.50 (0.27) N.A.
1.53 (0.40)  N.A. 
1.51 (0.34)  N.A. 
1.71 (0.62)  N.A. 
2.55 (0.25)*  N.A. 
2.32 (0.24)  N.A. 
1.60 (0.57)  N.A. 
1.29 (0.48)  N.A. 
1.23 (0.18)  N.A. 
1.26 (0.38)  N.A. 
2.94 (0.25)  93.8% 
2.94 (0.25)  93.8% 
2.06 (0.68)  25.0% 
2.25 (0.93)  56.3% 
2.69 (0.60)  75.0% 
2.65 (0.70)  76.5% 
3.00 (0.00)*  100.0% 
2.65 (0.70)  75.6% 
2.67 (0.50)  66.7% 
2.67 (0.62)  73.3% 
3.00 (0.00)*  100.0% 
2.29 (0.77)  47.1% 
3.00 (0.00)  100.0% 
2.88 (0.33)  88.2% 
2.88 (0.34)  87.5% 
2.88 (0.33)  88.2% 
2.63 (0.62)*  68.8% 
1.81 (0.91)  31.3% 
    Mean (SD)          Scoring ‘3’  
Primary 
tasks Secondary tasks 
Tertiary 
tasksBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/6
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those who did not have a clinical background. Some
authors have emphasized that nursing is the ideal
discipline from which to assume the role of CRC [5,16].
Our results do not support this premise: nurses and phy-
sicians who were appointed as CRCs took care of monitor-
ing activities more often than clinical ones. We suggest
that CRCs with a clinical background, in addition to the
responsibilities associated with that role, are well suited to
take on some investigators' responsibilities and thus act
also as sub-investigators. The possibility of assuming this
double role can be an advantage, but it is important to
keep in mind their key tasks as CRCs: to ensure that clini-
cal trials run smoothly and preserving data quality. This
situation has been well described by Ocker et al [23] who
pointed out that while the main focus of the staff nurses is
to provide patient care, the main focus of the research
nurse's role is the implementation of the protocol. In fact,
the two major advantages described in the literature of
having a CRC involved in clinical trials are: (a) to increase
recruitment rate [14,24] and (b) to have good data quality
[20]. Interestingly, the profile we discovered fits quite well
with a definition provided by the Association of Clinical
Research Professionals [25]: "A Clinical Research coodi-
nator, Study Site Research Nurse or Study Site Coordina-
tor, works at a clinical research site under the immediate
direction of a principal investigator, whose research activ-
ities are conducted under Good Clinical Practice regula-
tions. Among other tasks, CRC's peform site preparation,
patient screening and recruitment, patient enrolment,
conduct and ensure the quality of case report forms, main-
tain source documents, and ensure site quality".
We found differences between CRCs with greater involve-
ment in multinational clinical trials, and those with less
involvement. This may be explained by the fact that mul-
tinational clinical trials are more frequently sponsored by
the pharmaceutical industry, which imposes higher stand-
ards of quality. This may also explain why CRCs involved
in multinational trials play a greater role in query resolu-
tion and audit.
As data management activities are under-represented
amongst the tasks usually performed by CRCs, we advo-
cate the use of "Clinical Research Coordinator" as the job
title instead of "Data Manager". Alternatively, both terms
could be maintained: (a) data managers for those dealing
with data management activities (e.g. database set-up and
data entry) and who are usually working at a research
center; and (b) CRC for those involved in on-site activi-
ties, such as those identified in our study as standard tasks.
We also suggest that principal investigators rethink the
degree of involvement their CRCs have in certain research
activities, as these are also under-represented within
standard tasks, as we have defined them. Key personnel
involved in the clinical trial process should be familiar-
ized with study procedures; therefore CRCs should attend
investigators meetings more frequently. Participation in
protocol/CRF review and design should also be increased,
since the CRC can provide a worthy perspective on the
logistics of proposed study procedures [12]. In addition,
the involvement of CRCs in such activities will have a pos-
itive influence on their job satisfaction [26].
Workloads seem to vary greatly amongst the CRCs sur-
veyed, measured by the number of clinical trials they are
coordinating and the number of patients included. Those
with greater workloads were more often full time employ-
ees, as opposed to those with a lesser workload (82.4% vs.
50%, p = 0.07). Finally, CRCs in our study appeared to be
highly satisfied with their jobs, a finding similar to that
observed by Kellen et al [26].
Conclusion
Clinical Research Coordinators play a key role in the
implementation of oncology clinical trials, extending far
beyond mere data collection and/or administrative sup-
port, and directly contribute to the gathering of good
quality data. In line with these responsibilities, investiga-
tors and sponsors should take responsibility to ensure
that CRCs have adequate training in areas that we have
highlighted.
Further research is needed to systematically evaluate the
role of the CRC in other therapeutic areas, and in other
countries. In addition, it would be valuable to run a simi-
lar survey among investigators, in order to ascertain
whether the standard tasks CRCs are performing are in
line with those expected of this position.
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